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To clarify the mechanism of the antiallergic activity of Agaricus blazei Murill extract (ABME), the present paper used an in vivo
allergy model and an in vitro intestinal gut model. During OVA sensitization, the serum IgE levels decreased signiﬁcantly in ABME
group. Interleukin (IL)-4 and -5 produced from OVA-restimulated splenocytes was signiﬁcantly decreased, and anti-CD3ε/CD28
antibody treatment also reduced IL-10, -4, and -5 production and increased IFN-γ production in ABME group. These results
suggestthatoraladministrationofABMEimprovesTh1/Th2balance.Moreover,acoculturesystemconstructedofCaco-2cellsand
splenocytes from OT-II mice or RAW 264.7 cells indicated that the signiﬁcant increases in IFN-γ production by ABME treatment.
Therefore, it was concluded that the antiallergic activity of ABME was due to the activation of macrophages by epithelial cells and
the promotion of the diﬀerentiation of na¨ ıve T cells into Th1 cells in the immune.
1.Introduction
There are four types of hypersensitivity disease, and the
incidence of type I allergy has been increasing worldwide
[1, 2]. Type I allergy is characterized by a high level of
immunoglobulin E (IgE) antibodies arising from hypersen-
sitive reactions to allergens such as pollen or food. This
incidence caused by environmental factors, exposure to large
amounts of antigen, and genetics can aﬀect all age groups
at any time in life. In particular, there has been a marked
increase in the prevalence of allergies in children and young
adults [3].
Agaricus blazei Murill is one of the most intensively
studied medicinal mushrooms [4–6] among the mushrooms
used to treat many diseases [7–11]. It was reported that the
extract of A. blazei Murill had a potent antitumor activity
in mice, and its antitumor activity was postulated to be
exerted through mediation of the immune system of the host
by β-(1, 6)- and β-(1, 3)-glucan [5, 6, 12–15]. From these
reports, these functions of A. blazei Murill have been shown
to indirectly aﬀect immune systems.
The mechanism of the pathogenesis of type I allergy is
initiated by phagocytosis of allergens by antigen-presenting
cells (APC), which represent a part of the antigen on MHC
class II molecules to T cell receptors (TCR) on na¨ ıve T cells.
On the basis of their cytokine production proﬁles, CD4+ T
cells can be subdivided into two distinct populations, the T
helper type 1 (Th1) and T helper type 2 (Th2) cells [16].
Th2 cells predominantly produce interleukin (IL)-4 and IL-5
[17]. In contrast, Th1 cells mainly secrete cytokines such as
IL-2 and interferon (IFN)-γ [18, 19]. The balance between
Th1- and Th2-dominant immunity (Th1/Th2 balance) is
thought to be important for the development of various
diseases.
The gut forms a barrier between the internal environ-
ment and the outside. Of the various cells that exist in the
gut, intestinal epithelial cells (IEC), and macrophages are
some of the most important in gut immune systems. The
IEC physically prevent the invasion of numerous xenobiotics
such as microorganisms and their metabolites from the
intestine [20], and, macrophages, which are major APC, play
a key role in antigen-speciﬁc immunological responses. It2 Evidence-Based Complementary and Alternative Medicine
has been suggested that the activation of APC is a crucial
point in skewing of the balance between Th1 and Th2
immune responses [21]. Intestinal macrophages are major
cells in the human mononuclear phagocytic system and are
preferentiallylocalized in the subepithelial region [22]. Some
studies in gut immune systems have reported that APC
are able to select Th1 or Th2 diﬀerentiation [23, 24]. In
order to investigate the antiallergic eﬀects induced by oral
administration of functional foods, it is important to paper
theeﬀectsoffoodsthatareabletostimulateAPCandantigen
speciﬁc immunological responses through IEC.
Recently, many reports have shown that A. blazei Murill
has beneﬁcial eﬀects in vivo [12, 25, 26]. However, little
information is available on the mechanism of the antiallergic
eﬀects induced by oral administration of A. blazei Murill.
The aim of this study was to clarify the mechanism of the
antiallergic eﬀects exhibited after oral administration of A.
blazei Murill extracts (ABME) using an in vivo allergy model
mouse and an in vitro intestinal gut model.
2.MaterialsandMethods
2.1. Reagents and Preparation of A. blazei Murill Extract.
Dulbecco’s Modiﬁed Eagle Medium (DMEM), actinomycin
D, lipopolysaccharide (LPS) from E. coli O127, and murine
recombinant tumor necrosis factor (TNF)-α were purchased
from Wako Pure Chemical Industries (Osaka, Japan). Eagle’s
Minimum Essential Medium (MEM) was purchased from
Nissui pharmaceutical (Tokyo, Japan). RPMI 1640 medium,
MEM nonessential amino acids (NEAA), and trypsin were
purchased from GIBCO BRL (Grand Island, NY, USA).
PiCl was purchased from Tokyo Chemical Industries (Tokyo,
Japan). Mouse anti-2,4,6-trinitrophenyl (TNP) monoclonal
IgE was purchased from BD pharmingen (San Diego, USA).
Ovalbumin (OVA) and Al(OH)3 adjuvant were purchased
from Sigma (St. Luis, MO, USA). Antimouse CD3ε antibody
and antimouse CD28 antibody were purchased from Biole-
gend (San Diego, USA). The other chemicals and reagents
were ordinary commercial and guaranteed products. A.
blazei Murill (Iwade strain 101) extract (ABME) which was
composed of hot water extracts from mycelium and fruiting
body, and alkaline extracts of fruting body was donated by
the Iwade Mushroom Institute (Mie, Japan).
2.2. Mice. Female 3-week-old BALB/c mice were purchased
fromSLC(Shizuoka,Japan).Themicewerehousedinanair-
conditioned animal room at 23 ± 2◦C and acclimated for 7
days before the experiments. The mice were fed a laboratory
diet (Nihon Nosan, Yokohama, Japan) and water ad libitum.
OVA-speciﬁc TCR transgenic mice with a C57BL/6J back-
ground(OT-II)werepurchasedfromtheJacksonLaboratory
(Bar Harbor, ME). OT-II mice were originally generated by
Barnden et al. [27, 28]. The animal treatments in the present
study followed established rules and guidelines approved for
animal use and care at Kobe University (The Guidelines
for the Care and Use of Experimental Animals of Rokkodai
Campus, Kobe University).
2.3. IgE-Dependent PCA Reaction in BALB/c Mice. A passive
cutaneous anaphylaxis (PCA) reaction was induced with
PiCl to determine an approximate drinking concentration
of ABME. ABME was suspended in sterilized distilled water
at concentrations of 6.0, 1.2, 0.24, and 0.048mg/ml. Female
5-week-old BALB/c mice were given the extract suspension
in their drinking water for 4 days. Then, the mice were
passively sensitized by injecting 2μg/100μl of mouse anti-
TNP monoclonal IgE preparation intravenously into their
tail veins. The PCA reaction was evoked by painting 10μlo f
0.8% PiCl acetone-olive oil (1:1) solution onto the surface
of an earlobe. Ear thickness was measured before and 2h
after the PiCl challenge using a micrometer (Ozaki MFG Co.,
Ltd, Tokyo, Japan), and edema was calculated according to
diﬀerences in ear thickness before and after PiCl challenge.
2.4. OVA Immunization Protocol in BALB/c Mice. Female 4-
week-old BALB/c mice were given the ABME suspension
in their drinking water for 32 days. First sensitization was
achieved by intraperitoneally injecting 300μl PBS containing
10μg OVA mixed with 1mg Al(OH)3 adjuvant. Subse-
quently, the mice were challenged using an intraperitoneal
injection of 300μl PBS containing 10μgo fO V Am i x e d
with 0.5mg Al(OH)3 adjuvant every 5 days for 4 weeks
after the ﬁrst OVA injection. Some mice were injected with
Al(OH)3adjuvant as a control.
2.5.AnalysisofOVA-SpeciﬁcandAntigen-NonspeciﬁcCytokine
Responses in BALB/c Mice Splenocytes. Splenocytes were
prepared from each mouse followed by Segawa et al. [29]. To
determine OVA-speciﬁc cytokine production, the hemolyzed
splenocytes (5×106 cells/ml) were stimulated with 25μg/ml
OVA in a 96-well ﬂat-bottom well microplate for 72h. After
incubation, the culture supernatants were collected for the
measurement of cytokines using a Cytometric bead array
immunoassay kit (Beckman Coulter, Fullerton, CA, USA)
according to manufacturer’s protocol.
To determine antigen-nonspeciﬁc cytokine production
by T cells, 5μg/ml antimouse CD3ε antibody and 5μg/ml
antimouse CD28 antibody were used. The hemolyzed
splenocytes in RPMI1640 medium from the OVA-sensitized
mice were incubated in a glass dish (diameter: 9cm, Iwaki)
to remove adherent cells. After 2h incubation, nonadherent
cells in the cultured medium were collected and resuspended
at a concentration of 5×106 cells/ml in RPMI 1640 medium.
These nonadherent splenocytes were seeded onto the 96-
well microplate (5×105 cells/well) containing the antimouse
CD3ε antibody and 5μg/ml antimouse CD28 antibody. After
incubation for 48h, the culture supernatants were collected
for the measurement of cytokines using the same methods as
used for the OVA-speciﬁc cytokines.
2.6. Blood Samples. Blood samples from each mouse were
obtainedfromthetailveinevery5days,andwholebloodwas
collected from the postcaval vein on the day of sacriﬁce. To
prepare serum samples, the blood samples were centrifuged
at 10,000rpm for 10 minutes after incubation at roomEvidence-Based Complementary and Alternative Medicine 3
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Figure 1: In vitro intestinal gut model constructed with Caco-2 cells in apical compartment (a) and RAW264.7 cells in basolateral
compartment (b). Transwell inserts on which Caco-2 cells had been cultured were inserted into multiple plate wells containing RAW264.7
cells. Mineral oil (50μl/well) was added to the surface of the apical compartment (a) to mimic anaerobic conditions.
temperature for 30 minutes. Serum samples were stored at
−80
◦C until use.
2.7. Cell Culture. Cells of the human intestinal epithelial
cell line Caco-2 were cultured in DMEM (high glucose),
supplemented with 1% MEM-NEAA, 100U/ml penicillin,
100μg/ml streptomycin, and 10% heat-inactivated fetal
bovine serum (FBS), and cells of the murine macrophage
cell line RAW 264.7 were cultured in DMEM (glutamine,
low glucose) supplemented with 10% heat-inactivated FBS,
100U/mlpenicillin,and100μg/mlstreptomycin.Cellsofthe
murine ﬁbrosarcoma cell line L929 were cultured in MEM
supplemented with 10% FBS, 2 mM L-glutamine, 100U/ml
penicillin, and 100μg/ml streptomycin. All cell cultures were
incubated in a humidiﬁed 5% CO2 incubator at 37
◦C.
2.8. Coculture System Constructed with Caco-2 Cells/OT-II
Mice-Derived Splenocytes. To examine the eﬀects of ABME
on the OVA-speciﬁc response mediated via IEC, Caco-
2 cells and splenocytes from OT-II mice were cocultured
using Transwell inserts. OT-II mice-derived splenocytes were
preparedasdescribedabove.Caco-2cellswereseededat4.5×
105 cells/well in RPMI1640 onto transwell insert plates. The
cell culture medium was changed every 3 days until the cells
were fully diﬀerentiated. The splenocytes were suspended at
a concentration of 4.5 × 105 cells/well in RPMI1640 (500μl)
in a 24-well tissue culture plate and were incubated for 2h
in a 5% CO2 incubator at 37
◦C to precipitate cells on the
plate bottom. The transwell inserts on which the Caco-2
cells had been cultured were then added to the 24-well tissue
culture plate. Two hundred microliters of ABME (250μg/ml)
were applied to the apical side for 3h. After incubation, the
inserts were removed, and the splenocytes were restimulated
with 10μg/ml OVA for 72h. After incubation, the culture
supernatants were collected for the measurement of TNF-α
and IFN-γ.
2.9. Caco-2/RAW264.7 Cells Coculture System. RAW264.7
cells (4.5 × 105 cells/ml) were plated at 500μl/well in a 24-
well tissue culture plate containing DMEM and cultured for
24h. The DMEM was removed from the 24-well plate, and
transwell inserts containing diﬀerentiated Caco-2 cells were
placed to the 24-well plates preloaded with RAW264.7 cells.
Fresh RPMI 1640 media were used to replace the media
in both the apical (a) and basolateral (b) compartments
(Figure 1). Furthermore, mineral oil (50μl/well) was added
to the surface of the apical compartment to mimic anaerobic
conditions. After24hincubation, the mineraloil andculture
media of the apical and basolateral compartments were
changed for fresh oil and media, and then the cells were
incubated. After additional incubation for 12h, the culture
medium in the apical compartment was removed, and
RPMI1640 medium containing ABME (250μg/ml) or LPS
(25μg/ml) was applied for an additional 12h incubation.
The culture supernatants of the basolateral compartment
were collected for TNF-α and NO measurement.
2.10. Cytokines and IgE Content Measurement. TNF-α con-
tent was quantiﬁed using a cytotoxicity assay involving L929
cells (an actinomycin D-treated murine ﬁbroblast cell line)
and murine rTNF-α as the standard as described by Takada
et al. [30]. IFN-γ, IL-4, and total IgE contents were measured
with ELISA kits (OptEIA set, BD Biosciences, San Diego,
CA) in accordance with the manufacturer’s instructions.
Nitrite as the end product of Nitric oxide (NO) was mea-
sured by using Griess reagent (1% sulfanilamide/0.1 % N-
1-naphthylethylenediamine dihydrochloride/2.5 % H3PO4)
followed by Green et al. [31].
2.11. Immunoprecipitation of ABME with Anti-FIII-2b Poly-
clonal Antibody. Anti-FIII-2-b polyclonal antibody was pre-
pared as described by Mizuno et al. [32]. The antibody was
incubatedwithABME(250μg/ml)orFIII-2-b(250μg/ml)at
4◦C for 2h, and then the reaction mixture was centrifuged at
7000rpm for 5 minutes. The supernatant was added to the
apical side of the coculture system.
2.12.StatisticalAnalysis. Dataareexpressedasthemean±SE.
Statistical analysis was performed using the Student’s t-test.
Statistical signiﬁcance was deﬁned as P<. 05.4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Eﬀects of ABME on the passive cutaneous anaphylaxis
reaction in the ears of BALB/c mice. BALB/c mice were given 0.048,
0.24, 1.2, or 6.0mg/ml ABME in their drinking water, and passive
cutaneousanaphylaxis(PCA)wasinducedasdescribedinMaterials
and Methods. Edema was measured before and after PiCl challenge.
Valuesrepresentthemeans ±S.E.of4miceineachgroup. ∗P<. 05,
signiﬁcantly diﬀerent from the values of the control group.
3. Results
3.1. Suppression of the Anti-TNP IgE-Mediated PCA Reac-
tion by Oral Administration of ABME. The PCA reaction
was evoked by painting of PiCl. Oral administration of
ABME did not cause any signiﬁcant diﬀerence in weight or
drinking amount compared with the control group at any
concentration throughout the experiment (data not shown).
Furthermore, results demonstrated that the administration
ofABMEatconcentrationsof1.2and6.0mg/mlsigniﬁcantly
inhibited edema compared with the control group in a dose-
dependent manner (Figure 2).
3.2. Downregulation of Serum Immunoglobulin E Levels by
Oral Administration of ABME in BALB/c Mice. Antiallergic
eﬀects of ABME on allergen-speciﬁc responses were exam-
ined using BALB/c mice sensitized with OVA. ABME was
administered to the mice at the same concentrations in the
PCA reaction experiment. Oral administration of ABME
did not cause signiﬁcant changes in weight loss or drinking
amount (data not shown). IgE levels increased rapidly after
the second injection and then gradually increased until the
forth injection in the control group (Figure 3). However,
the IgE levels in the ABME-treated group were lower than
those in the control group after the third injection, and
thereafter they were almost the same. On day 14 of this
treatment, the IgE levels in the mice administered 6.0 or
1.2mg/ml ABME had signiﬁcantly decreased to 8.5 ± 1.1
and 10.1±0.5μg/ml, respectively, compared with the control
mice (14.1 ± 0.6μg/ml). These results indicated that oral
administration of ABME downregulated the IgE level in
serum at concentrations above 1.2mg/ml.
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Figure 3: Eﬀect of ABME on OVA sensitization in BALB/c mice
The arrows show the days corresponding to the injections of OVA.
S e r u mw a so b t a i n e df r o me a c hm o u s eo nt h ed a yb e f o r ee a c hO V A
injection,andtheleveloftotalIgEwasdeterminedbyELISA.Values
represent the means ± S.E. of 5 mice in each group. ∗P<. 05,
signiﬁcantly diﬀerent from the values of the control group.
3.3. Inhibitory Eﬀect of ABME on Immune Responses in
Splenocytes from OVA-Sensitized BALB/c Mice. To examine
OVA-speciﬁc cytokine responses in OVA-sensitized mice,
their splenocytes were treated with OVA (25μg/ml). The IL-
4 production in the 6.0 and 1.2mg/ml ABME groups was
signiﬁcantly decreased to 19.1 ± 11.7a n d1 5 .1 ± 14.0pg/ml
compared with the control group (183.3 ± 53.3pg/ml)
(Figure 4(a)). Furthermore, the IL-5 production was signif-
icantly decreased to 50.4 ± 27.5pg/ml in the 6.0mg/ml of
ABME group compared with the control group (369.1 ±
43.5pg/ml) (Figure 4(b)). However, IFN-γ production, a
typical Th1 cytokine, was lower than the detection limit in
all groups. These results indicated that oral administration
of ABME decreased Th2 response of splenocytes sensitized
by OVA. To conﬁrm this, we focused on the T cell antigen
receptor signal transduction pathway.
When antigen presenting cells (APC) such as
macrophages present an antigenic fragment, T cell activation
is dependent on signals delivered through the T cell receptor
(TCR)-CD3 complex and the major T cell costimulatory
receptor CD28 on the T cell [33–35]. To examine Th1/Th2
cytokine responses mediated via these signaling pathways,
spleencellsweretreatedsimultaneouslywithanti-CD3ε-and
anti-CD28 antibodies. IL-4, IL-5, and IL-10 production was
suppressed by ABME administration in a dose-dependent
manner and signiﬁcantly decreased to 2.4 ± 0.4ng/ml,
656.2 ± 44.1pg/ml, and 670.0 ± 70.5pg/ml, respectively ,
in 6.0mg/ml the ABME group (Figures 5(a)−5(c)). On the
other hand, IFN-γ production was signiﬁcantly increased
compared with the control group (Figure 5(d)). These
results suggested that the Th1 response in the splenocytes
wasincreasedandtheTh2responsewasdecreaseddependingEvidence-Based Complementary and Alternative Medicine 5
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Figure 4: Eﬀect of ABME on the production of the Th2 cytokines IL-4 and 5 from antigen-restimulated splenocytes in OVA-sensitized mice.
Two days after the last OVA injection, the spleen cells isolated from each mouse were restimulated with 25μg/ml OVA. After incubation at
37oC for 72h, the levels of IL-4 (a) and IL-5 (b) in the culture supernatants were determined using a cytometric bead array immunoassay.
Values represent the means ± S.E. of 5 mice in each group.∗P<. 05,
∗∗P <. 01, signiﬁcantly diﬀerent from the values of the control group.
on the concentration of ABME ingested when the T cell
antigen receptor signal transduction pathway was activated.
3.4. Eﬀect of ABME on OVA Stimulated Splenocytes Prepared
from OT-II Mice via Caco-2 Cells in CoCulture System. As
shown in Figure 5, oral administration of ABME dose-
dependently decreased the Th2 response and increased the
Th1 response in the spleens of OVA-sensitized mice. In order
toinvestigatehoworallyadministeredABMEaﬀectsimmune
cells in the gut, the eﬀect of ABME on IFN-γ production
was measured in a coculture system constructed of Caco-2
cells and splenocytes prepared from OT-II mice. Since the
T cells in splenocytes from OT-II mice highly express an
OVA-speciﬁc T cell receptor (TCR), the Th1/Th2 cytokine
balance can be examined by using OVA as a stimulator. As
shown in Figure 6(a), treatment of Caco-2 cells with ABME
prior to the stimulation of splenocytes with OVA signiﬁ-
cantly increased IFN-γ production on the basolateral side
compared with that observed without ABME stimulation.
Nosigniﬁcant changewasrecognized in thecoculturesystem
with and without ABME under nonstimulation with OVA.
Similarly, ABME pretreatment enhanced TNF-α production
through Caco-2 cells (Figure 6(b)). These results suggested
that the lymphocytes that can produce TNF-α were activated
by ABME pretreatment via Caco-2 cells, and then, OVA-
speciﬁc na¨ ıve T cells were diﬀerentiated into Th1 cells, which
can produce INF-γ.
3.5. Eﬀect of ABME on RAW264.7 Cells via Caco-2 Cells
in the Coculture System. In the Caco-2/OT-II splenocytes
coculture system, ABME induced TNF-α production from
OVA restimulated splenocytes via Caco-2 cells. TNF-α
is one of the major cytokines secreted from APC such a
macrophages and dendritic cells. Then, the eﬀects of ABME
on macrophages were examined using Caco-2/RAW264.7
coculture system. ABME (250μg/ml) treatment for 12h
to the apical compartment signiﬁcantly upregulated the
TNF-α production from RAW264.7 cells (Figure 7(a)).
However, ABME did not induced TNF-α production from
RAW264.7 cells directly (Figure 7(b)). NO production did
not induced by ABME treatment (Figure 7(c)), although the
direct treatment of ABME to RAW 264.7 did (Figure 7(d)).
These results indicate that ABME cannot induce TNF-α
production from RAW264.7 cells without interacting with
Caco-2 cells, and Caco-2 cells can cancel NO production
from RAW 264.7 cells.
To identify which compounds in ABME enhance TNF-
α production from RAW264.7 cells, immunoprecipitation
using an anti-FIII-2-b antibody was applied. This antibody
recognizes the FIII-2-b fraction which was puriﬁed as the
most active fraction in alkaline-soluble fractions of A. blazei
Murill [12]. As shown in Figure 8, the anti-FIII-2-b antibody
signiﬁcantly suppressed TNF-α production from RAW264.7
to a control levels in a coculture system in which Caco-2 cells
were treated FIII-2-b or ABME. This result indicated that the
active compound contained in ABME is FIII-2-b.6 Evidence-Based Complementary and Alternative Medicine
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Figure 5: Eﬀect of ABME on the cytokine proﬁle of anti-CD3ε/CD28 antibody-stimulated splenocytes in OVA-sensitized mice. Spleen cells
from the mice of each group were stimulated with 5μg/ml each of anti-CD3ε/28 antibody at 37
◦C for 48h. After incubation, the IL-4 (a),
IL-5 (b), IL-10 (c), and IFN-γ (d) in the culture medium were determined using a cytometric bead array immunoassay. Values represent the
means ± S.E. of 5 mice in each group.∗P<. 05,
∗∗P <. 01, signiﬁcantly diﬀerent from the values of the control group.
4. Discussion
A. blazei Murill is considered to be one of the most
important edible and medicinal mushrooms in Japan. It
was traditionally used for the treatment of many com-
mon diseases like atherosclerosis, hepatitis, hyperlipidemia,
diabetes, dermatitis, cancer, and allergy disease [15]. Choi
et al. [26] demonstrated that the water extract of the
A. blazei Murill fruiting body suppressed allergic edema
after oral administration and reduced histamine release
by direct incubation with mast cells. In general, recent
studies are focusing on elucidation action mechanisms for
mushrooms extracts, including ABME, hence this study on
the mechanism for the antiallergic eﬀects exhibited after oral
administration of ABME in vivo and in vitro systems.
The PCA reaction is a simple method for assessing the
inhibitory eﬀects of orally administered compounds on type
I allergy. Many beneﬁcial foods and components such as
tea leave saponins [36] and mushrooms [10, 37]h a v eb e e n
demonstrated antiallergic eﬀects using this method. In this
study, ABME suppressed PiCl-induced edema in a dose-
dependent manner (Figure 2). Moreover, ABME exerted a
signiﬁcant suppressive eﬀect on the serum IgE levels of OVA-
sensitized mice at concentrations of 1.2mg/ml and above
(Figure 3). Similarly, Segawa et al. [29] demonstrated that
oral administration of heat-killed Lactobacillus brevis inhib-
ited total IgE production by improving the Th1/Th2 balance
by enhancing IL-12 and IFN-γ production and inhibiting
IL-4 production from OVA-sensitized mice splenocytes. It
was demonstrated that the levels of IL-4 and IL-5 secretedEvidence-Based Complementary and Alternative Medicine 7
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Figure 6: Eﬀe c to fA B M Eo nI N F - γ and TNF-α production from OVA-stimulated splenocytes prepared from OT-II mice via Caco-2 cells
using a coculture system. Splenocytes were cultured in 24-wells plates for 2h in 5% CO2 and incubated at 37
◦C to precipitate cells on the
bottom of the plates. Then, the transwell inserts on which the Caco-2 cells had been cultured were placed into the 24 well plates, which
had been preloaded with splenocytes. Two hundred microliters of ABME (250μg/ml) were applied to the apical side and incubated for 3h.
After incubation, the inserts were removed, and the splenocytes were restimulated with 10μg/ml OVA at 37
◦Ci naC O 2 incubator for 72h.
After incubation, the culture media were collected for the measurement of IFN-γ (a) and TNF-α (b) contents as described in Materials and
Methods. Values represent the means ± SE. (n = 3). ∗P<. 05, signiﬁcantly diﬀerent from the values of the control group.
from splenocytes restimulated with OVA in the 6.0 and
1.2mg/ml ABME groups were lower than those in the
control groups (Figure 4). Furthermore, restimulation with
anti-CD3ε/CD28 antibodies diminished IL-10 secretion but
increased IFN-γ production in addition to decreases of IL-4
and IL-5 production (Figure 5). Consequently, these results
suggested that the oral administration of ABME shifted
the Th1/Th2 balance towards Th1 and downregulated IgE
levels. It was reported that ABME enhanced IL-12 and IL-
18mRNAexpressioninmacrophages[38].Therefore,ABME
may aﬀect APC to modulate the Th1/Th2 balance.
It has been found that the gut immune cells are shifted
t ot h eT h 2t y p ei na l l e r g i cp a t i e n t s[ 24]. As various immune
cells are aﬀected by IEC in the gut [39], we used a coculture
system using splenocytes from OT-II mice, which possess
CD4+ T cells that highly express the OVA-speciﬁc TCR,
and Caco-2 cells for assessing the eﬀects of ABME on
the diﬀerentiation of T cells via IEC. IFN-γ and TNF-
α production was signiﬁcantly increased in the ABME-
and OVA-stimulated coculture system as compared to that
without ABME treatment (Figure 6). IFN-γ is secreted from
Th1 cells and promotes the proliferation of Th1 cells [40].
TNF-α is one of the major cytokines secreted from activated
APC [41–43]. Considering these results, our hypothesis is
that ABME activates APC by interacting with IEC and then
induces Th1 diﬀerentiation of na¨ ıve T cells in splenocytes by
increasing the expression of Th1 cytokines and decreasing
that of Th2 cytokines. This is the ﬁrst report to show the
eﬀectsofABMEviaIEC.Toconﬁrmthishypothesisinwhich
ABME activates APC through IEC, we examined whether
ABME could activate macrophages in a slightly modiﬁed
coculture system constructed of Caco-2 and RAW264.7 cells
[44]. ABME enhanced TNF-α production from RAW264.7
cells in the coculture system but did not induce it during
direct treatment of RAW264.7 cells alone. Moreover, nitric
oxide was not detected in coculture system, albeit direct
treatment of ABME to RAW 264.7 produced it (Figure 7).
Recently, Nakao et al. [45] reported that hydrogen peroxide
(H2O2) induced the production of TNF-α in RAW 264.7
cells and did not support nitric oxide production unlike
LPS. These results may suggest that ABME may indirectly
aﬀect immune cells such as macrophages through IEC which
is produces H2O2 as a second messenger. However, further
investigations are necessary to clarify how ABME activates
macrophages through IEC.
It was demonstrated that ABME suppressed IgE content
in OVA-sensitized mice by shifting the Th1/Th2 balance to
Th1 and that IEC are absolutely imperative for activating
APC, which induce the diﬀerentiation of na¨ ıve T cells to
Th1 type cells. It has been reported that A. blazei Murill
contain β-glucans including the FIII-2-b fraction [6, 12–14].
We showed that TNF-α production from the basolateral side8 Evidence-Based Complementary and Alternative Medicine
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Figure 7: TNF-α and NO production in the coculture system or RAW264.7 cells alone treated with ABME or LPS ABME or LPS was added
into the apical compartment of the Caco-2/RAW264.7 coculture system (a, c) or added directly into the RAW264.7 cells alone (b, d) and was
thenincubatedfor12h.Afterincubation,thesupernatantswerecollected.TNF-αandNOsecretionintotheculturesupernatant(basolateral
compartment) was determined by a cytotoxicity assay and Griess reagent. Values represent the means ± SE. (n = 3). ∗P<. 05, signiﬁcantly
diﬀerent from the values of the control group.
of the coculture system was decreased to control levels when
this antibody was pretreated with FIII-2-b or ABME solution
(Figure 8). This result suggested that the active compound in
ABME producing its antiallergic eﬀect is FIII-2-b.
In conclusion, this paper demonstrates that FIII-2-b
in ABME activates macrophages through IEC, but without
them. These ﬁndings suggest that an activation process
linked to macrophages is involved IEC. H2O2 which wasEvidence-Based Complementary and Alternative Medicine 9
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Figure 8: Eﬀect of anti-FIII-2-b antibody on TNF-α production induced by ABME in a coculture system. Anti-FIII-2-b antibody or isotype
IgG1 (25ml/well) were incubated with ABME for 2h and centrifuged at 7000rpm for 5 minutes. The supernatant was added to the apical
compartment of the Caco-2/RAW264.7 co-culture system for 3h. After the incubation, the supernatant from the basolateral side was
collected, and TNF-α content was measured using a killing assay. Values represent the means ± S.E. (n = 3). ∗P<. 05 and
∗∗P <. 05,
signiﬁcantly diﬀerent from the values for FIII-2-b and ABME treatment, respectively.
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Figure 9: Shift in Th1/Th2 balance to Th1 by ABME through intestinal epithelial cells. An intestinal epithelial cell is stimulated by FIII-2-b
in ABME, which binds to a certain receptor. This stimulus produces second messengers, likely H2O2. Macrophages result in enhancement of
TNF-αandIFN-γ production.Produced INF-γ aﬀectsTh1/Th2balancewhichisimportantforallergy,andpromotesthenegativeregulation
of IL-4, 5, 10 which induce Th2 cell dominance, resulting in Th1 cell dominance in immune system.10 Evidence-Based Complementary and Alternative Medicine
produced from Caco-2 plays an important role of a second
messenger to produce TNF-α from macrophages and is
involved in the signal transduction to promote the diﬀeren-
tiation of na¨ ıve T cells into Th1 cells (Figure 9).
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